CORRESP Filing
Benitec Biopharma Inc.
Date: Sept. 26, 2025 · CIK: 0001808898 · Accession: 0001193125-25-220122
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290455
Letter
BENITEC BIOPHARMA INC. 3940 Trust Way Hayward, California 94545 September 26, 2025 VIA EDGAR Joshua Gorsky Joe McCann Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Registration Statement on Form S-3 (File No. 333-290455)
Re: Benitec Biopharma Inc.
Dear Mr. Gorsky and Mr. McCann: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-290455) so that it may become effective at 4:00 p.m. Eastern Time on September 29, 2025, or as soon thereafter as practicable. Very truly yours,
BENITEC BIOPHARMA INC.
By: /s/ Dr. Jerel Banks
Name: Dr. Jerel Banks
Title: Chief Executive Officer
cc: Matt O'Loughlin, Proskauer Rose LLP Louis Rambo, Proskauer Rose LLP
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
BENITEC BIOPHARMA INC. 3940 Trust Way Hayward, California 94545 September 26, 2025 VIA EDGAR Joshua Gorsky Joe McCann Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Re:
Benitec Biopharma Inc.
Registration Statement on Form S-3 (File No. 333-290455)
Dear Mr. Gorsky and Mr. McCann: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-290455) so that it may become effective at 4:00 p.m. Eastern Time on September 29, 2025, or as soon thereafter as practicable. Very truly yours,
BENITEC BIOPHARMA INC.
By:
/s/ Dr. Jerel Banks
Name:
Dr. Jerel Banks
Title:
Chief Executive Officer
cc: Matt O'Loughlin, Proskauer Rose LLP Louis Rambo, Proskauer Rose LLP